Skip to main content
PRVA
NASDAQ Industrial Applications And Services

Privia Health Q2 Revenue Surges 21% to $633M, Raises Full-Year Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$24
Mkt Cap
$3.019B
52W Low
$19.08
52W High
$28.82
52W Position info
26% above low
Off High info
17% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

PRVA sits 26% above its 52-week low of $19.08.

Summary

Privia Health reported Q2 2026 revenue of $632.6M (+21.4% YoY) and net income of $9.0M (+236.7% YoY), beating estimates. Full-year guidance was raised for all key financial metrics.

Updates

  1. · SEC 10-Q — Credit facility increased to $250 million and extended through 2031 via May 6, 2026 amendment.


Key Events · Earnings and Guidance · PRVA

  • Q2 Revenue Beats Estimates

    Revenue reached $632.6 million, up 21.4% year-over-year, driven by growth in implemented providers and value-based care attributed lives.

  • Net Income Triples

    Net income surged 236.7% to $9.0 million, or $0.07 per share, compared to $2.7 million in Q2 2025.

  • Adjusted EBITDA Jumps 29%

    Adjusted EBITDA rose to $37.4 million, with margin expanding to 28.3% from 25.2% a year ago.

  • Full-Year Guidance Raised

    Management lifted its 2026 outlook for practice collections, GAAP revenue, care margin, platform contribution, and adjusted EBITDA, now expecting adjusted EBITDA of $145-$155 million.


Analysis · PRVA · Industrial Applications And Services

A standout quarter saw revenue jump 21% to $632.6 million and net income more than triple to $9 million. The company raised its full-year outlook across all key metrics, signaling confidence in sustained momentum. This performance, against a backdrop of recent insider selling, provides a strong fundamental counterpoint and could shift investor sentiment.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PRVA was trading at $24.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3B. The 52-week trading range was $19.08 to $28.82. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PRVA - Latest Insights

PRVA
Nov 18, 2026, 8:38 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.26
Real-time Price: $25.38 info
Change: +$0.115 (+0.46%) info
Market Cap: $3.242B info
PRVA
Nov 18, 2026, 8:30 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $25.26
Real-time Price: $25.38 info
Change: +$0.115 (+0.46%) info
Market Cap: $3.242B info
PRVA
Nov 05, 2026, 8:50 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $23.19
Real-time Price: $25.38 info
Change: +$2.18 (+9%) info
Market Cap: $3.242B info
PRVA
Nov 05, 2026, 6:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.00
Real-time Price: $25.38 info
Change: +$3.38 (+15%) info
Market Cap: $3.242B info
PRVA
Nov 05, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.00
Real-time Price: $25.38 info
Change: +$3.38 (+15%) info
Market Cap: $3.242B info